Detalle de: Vascular endothelial growth factor (VEGF) serum levels are associated with survival in early stages of lung cancer patients
| Title | Vascular endothelial growth factor (VEGF) serum levels are associated with survival in early stages of lung cancer patients |
| Abstract |
Aim Evaluate the serum vascular endothelial growth factor (VEGF) levels in the prognosis of lung cancer patients. Methods Fifty-four serum samples were analyzed for VEGF concentrations (79.3% nonsmall cell lung cancer (NSCLC) and 20.7% small cell lung cancer). Results Patients with serum VEGF-A levels higher than the mean of the patients studied (434.93 pg/mL) presented a shorter median survival time than those with lower levels (p =.04), as in patients with NSCLC tumors (p =.04) and in those with stages I-II (p Conclusion Elevated VEGF serum levels have a negative prognostic impact on survival in NSCLC and early stages of lung cancer patients. |
| Apa Reference | Pau, E. C. S., Arias, F. C., Pelaez, E. C., Trueba, I. M., Hernández, I. S., Molina, G. M. M., Balsalobre, R. M., López, S. S., Gómez-Pinillos, A., & Toledo Lobo, M. del V. (2010). Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients. Cancer Investigation, 28(4), 393–398. 10.1080/07357900903405900 |
| Doi | 10.3109/07357900903405900 |
| Publication Date | Apr 2010 |
| Publication Type | Article |
| Researcher | Enrique Carrillo de Santa Pau |
| Ontology | Clinical data |
| Research Groups | Computational Biology (IMDEA) |
| Tools |